Prognostic test for lung cancer on horizon
This article was originally published in Clinica
Executive Summary
The discovery of two gene expression profiles could pave the way to prognostic tests for lung cancer. The researchers, from the Mayo Clinic in Rochester, Minnesota, believe that the tests will lead to "better personalised treatment options" for sufferers of non-small cell lung cancer (NSCLC).